2007
DOI: 10.1186/gb-2007-8-1-r12
|View full text |Cite
|
Sign up to set email alerts
|

Impairment of organ-specific T cell negative selection by diabetes susceptibility genes: genomic analysis by mRNA profiling

Abstract: Background: T cells in the thymus undergo opposing positive and negative selection processes so that the only T cells entering circulation are those bearing a T cell receptor (TCR) with a low affinity for self. The mechanism differentiating negative from positive selection is poorly understood, despite the fact that inherited defects in negative selection underlie organ-specific autoimmune disease in AIRE-deficient people and the non-obese diabetic (NOD) mouse strain

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

6
22
0

Year Published

2008
2008
2021
2021

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 39 publications
(28 citation statements)
references
References 107 publications
(102 reference statements)
6
22
0
Order By: Relevance
“…Although it is generally accepted that expression of CD69 identifies DP thymocytes recently engaged in positively-selecting TCR-pMHC interactions 3, 65 , it is not clear which (if any) fraction of TCR-triggered CD69 + DP thymocytes is doomed to die following TCR engagement with negatively-selecting pMHC ligands 72-77 . To address this question, we highlighted those genes that have been reproducibly associated with negative selection in TCR transgenic models ( Nr4a1 (NUR77), Bcl2l11 (BIM), Pdcd1 (PD1), and Gadd45b 29, 30, 78 ) on a volcano plot comparing the CD69 + DP and small DP stages (Fig. 6a).…”
Section: Resultsmentioning
confidence: 99%
“…Although it is generally accepted that expression of CD69 identifies DP thymocytes recently engaged in positively-selecting TCR-pMHC interactions 3, 65 , it is not clear which (if any) fraction of TCR-triggered CD69 + DP thymocytes is doomed to die following TCR engagement with negatively-selecting pMHC ligands 72-77 . To address this question, we highlighted those genes that have been reproducibly associated with negative selection in TCR transgenic models ( Nr4a1 (NUR77), Bcl2l11 (BIM), Pdcd1 (PD1), and Gadd45b 29, 30, 78 ) on a volcano plot comparing the CD69 + DP and small DP stages (Fig. 6a).…”
Section: Resultsmentioning
confidence: 99%
“…Variations of another 3 genes could be connected with B cell activation: CD69 was overexpressed 4 fold in IgA tumors (similar to its overexpression polyclonal α1KI B cells) [ 6 , 38 ]); Trim12 (a repressor of lymphocyte activation) [ 39 ] was down-regulated 27 fold in IgA+ tumors, so as the gene for MARCH1, an E3 ubiquitin protein ligase targeting some membrane receptors for degradation and down-regulated by B cell activation [ 40 ].…”
Section: Resultsmentioning
confidence: 99%
“…Zfp467 has been identified as an enriched nuclear protein in quiescent leukemic hematopoietic stem cells, implicating Zfp467 as a regulator of hematopoietic stem cell function (71) in addition to the role we have identified in MSC differentiation. In support of Zfp467 playing a role in hematopoiesis, a search for diabetes susceptibility genes found the protein to be a positive regulator of T cell selection in the thymus (71) and thereby associating Zfp467 in T-cell survival and maturation, because defective negative selection for T cell receptor with low self affinity can result in autoimmune diabetes (72)(73)(74).…”
Section: Discussionmentioning
confidence: 99%